We get the drugs and another claim form from the pharmacy, cost (it's the antibiotics): 875F.
Pharmacy cost for antimigraine medication use accounted for 78% of total migraine-related costs.
An increase in all-cause pharmacy cost by $1,010 and decrease in all-cause medical cost by $3,407 were shown in the antimigraine medication use group.
Notably, although pharmacy cost was reduced without taking prescription drugs, total health care costs were increased due to heavy costs on medical utilization.
This variable is composed of the sum of medical staff cost, non-medical staff cost, medical material cost and pharmacy cost.
This finding may underscore the significance of our findings, as increased pharmacy cost resulting from antimigraine medications may by justified by total medical care cost reduction in patients with migraine (after adjusting for covariates).
To identify pharmacy cost outlier patients in Primary Care, describing epidemiological differences between normal users and outliers; and to study the explanatory power of risk adjustment tools based on Adjusted Clinical Groups (ACG) as regards the variability of pharmacy expenditure for both groups of patients.
*Outcomes refer to top 5% Year-2 pharmacy cost group.
This includes fixed cost, variable cost and pharmacy cost.
The analysis model involves five steps: 1) Actual pharmacy cost and predicted pharmacy cost per county council.
Due to the distinct cost distribution for each cost outcome, separate models were estimated for total inpatient cost, ambulatory care excluding pharmacy cost, and pharmacy cost.
